Latest News

  • INNOVATION

    25 Feb 2026

    Can AI Rethink How New Drugs Are Found?

  • PARTNERSHIPS

    24 Feb 2026

    Lilly Deepens AI Push in Obesity Drug Race

  • INVESTMENT

    23 Feb 2026

    Another Shot in the Obesity Gold Rush

  • MARKET TRENDS

    19 Feb 2026

    Precision Medicine Rises as Biomarkers Drive Change

Pfizer Steps Up Obesity Push With Metsera Deal

Pfizer corporate logo displayed outside office building

PARTNERSHIPS

17 Feb 2026

US drugmaker agrees multibillion-dollar acquisition to bolster metabolic pipeline and challenge leaders in weight-loss therapies

FDA approved sign displayed on laptop and documents during regulatory review.

REGULATORY

4 Dec 2025

FDA Draft Sparks a Metabolic Shake Up

New FDA guidance pushes durability to the forefront as industry giants deepen their metabolic bets

Blue Excelsior Sciences logo featuring arrow loop icon on a white background.

INNOVATION

3 Dec 2025

AI Tools Stir Cautious Shift in US Metabolic Innovation Race

Firms explore AI to speed discovery as analysts note opportunity, uncertainty and a fluid competitive landscape

Logo of the Coalition for Metabolic Health displayed over imagery of nutritional and health-related elements

PARTNERSHIPS

2 Dec 2025

Metabolic Care Gets a National Wake Up Call

New US metabolic alliance pushes earlier care and integrated treatments; firms like Lilly and Novo Nordisk should prepare for shifting sta...

Bathroom scale with measuring tape on tiled floor symbolising weight management

INVESTMENT

1 Dec 2025

A MASH Contender Puts Roche in the Spotlight

Roche’s move to acquire 89bio boosts a leading MASH therapy and opens new partnership opportunities across metabolic medicine

Roche corporate sign in front of modern office building on a clear day

PARTNERSHIPS

25 Nov 2025

Pharma Giants Chase the Next Liver Breakthrough

Novo and Roche spark a US push for new metabolic liver treatments as combo strategies take hold

3D rendering of a metabolic cell structure surrounded by blood components.

INSIGHTS

24 Nov 2025

Beyond GLP1: A New Race to Fix the Body’s Fuel System

OrsoBio pursues deeper metabolic repair beyond GLP-1 drugs, signaling a shift toward long-term health gains; investors should watch emergi...

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.